dc.contributor.author | Philippe, RS | |
dc.contributor.author | Sarah, Duncan | |
dc.contributor.author | Joshua, Kimani, | |
dc.contributor.author | Alexander, Thiong’o | |
dc.contributor.author | Juma, Shafi, | |
dc.contributor.author | Scott, McClelland, | |
dc.contributor.author | Eduard, Sanders J | |
dc.contributor.author | George, Zhanel | |
dc.contributor.author | Nicholas, Maraguri, | |
dc.contributor.author | Mehta, Supriya D | |
dc.date.accessioned | 2015-07-24T07:43:26Z | |
dc.date.available | 2015-07-24T07:43:26Z | |
dc.date.issued | 2012-05 | |
dc.identifier.citation | Sex Transm Dis. 2012 May; 39(5): 332–334. | en_US |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328140/ | |
dc.identifier.uri | http://hdl.handle.net/11295/88755 | |
dc.description.abstract | We have recently reported high levels of fluoroquinolone resistance in a single region of Kenya. In this manuscript, we report high prevalence of fluoroquinolone resistance (53.2%) in Neisseria gonorrhoeae isolates from four clinics in three additional regions of Kenya. These findings highlight the need to change first-line treatment in these settings and the need to evaluate empiric management guidelines for treatment of gonococcal infection in Kenya. | en_US |
dc.language.iso | en | en_US |
dc.publisher | University of Nairobi | en_US |
dc.subject | Fluoroquinolone, Sexually transmitted disease, gonorrhoea, cefixime, azithromycin | en_US |
dc.title | Emergence of Fluoroquinolone Resistance in Neisseria gonorrhoeae Isolates from Four Clinics in Three Regions of Kenya | en_US |
dc.type | Article | en_US |
dc.type.material | en | en_US |